A study of Methylphenidate and Pharmacogenomic Calibration
Rochester, MN
The purpose of this study is to evaluate the predictive value of a custom designed SNP panel test on overall side effect burden caused by methylphenidate at week 8, as well as treatment response. The measure of overall side effect burden will take into account both the number and severity of side effects.